Repligen reported $283.71M in Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Bio Techne TECH:US $ 255.91M 3.1M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bristol Myers Squibb BMY:US $ 42060M 2912M
Bruker BRKR:US $ 1185M 31.4M
Catalent CTLT:US $ 4186M 34M
Charles River Laboratories CRL:US $ 2999.58M 320.78M
Danaher DHR:US $ 20062M 1716M
Exact Sciences EXAS:US $ 2242.84M 43.16M
Fluidigm FLDM:US $ 64.55M 35.49M
General Electric GE:US $ 32518M 1116M
Henry Schein HSIC:US $ 858M 8M
Illumina ILMN:US $ 1740M 0M
IQVIA Holdings Inc IQV:US $ 12.77B 130M
Mettler Toledo International MTD:US 1.93B 55.94M
Nanostring Technologies NSTG:US $ 225.88M 0.37M
Orasure Technologies OSUR:US $ 2.63M 0.28M
Pacific Biosciences Of California PACB:US $ 896.37M 0.15M
Peregrine Pharmaceuticals PPHM:US $ 142.18M 0.14M
Perkinelmer PKI:US $ 4488.49M 379.21M
Repligen RGEN:US $ 283.71M 0.44M
Thermo Fisher Scientific TMO:US $ 30260M 2995M
Waters WAT:US $ 1484.37M 40.25M
West Pharmaceutical Services WST:US $ 252M 0.5M